Where to Stand with Stromal Cells and Chronic Synovitis in Rheumatoid Arthritis?
Jean-Marc BrondelloFarida DjouadChristian JorgensenPublished in: Cells (2019)
The synovium exercises its main function in joint homeostasis through the secretion of factors (such as lubricin and hyaluronic acid) that are critical for the joint lubrication and function. The main synovium cell components are fibroblast-like synoviocytes, mesenchymal stromal/stem cells and macrophage-like synovial cells. In the synovium, cells of mesenchymal origin modulate local inflammation and fibrosis, and interact with different fibroblast subtypes and with resident macrophages. In pathologic conditions, such as rheumatoid arthritis, fibroblast-like synoviocytes proliferate abnormally, recruit mesenchymal stem cells from subchondral bone marrow, and influence immune cell activity through epigenetic and metabolic adaptations. The resulting synovial hyperplasia leads to secondary cartilage destruction, joint swelling, and pain. In the present review, we summarize recent findings on the molecular signature and the roles of stromal cells during synovial pannus formation and rheumatoid arthritis progression.
Keyphrases
- bone marrow
- rheumatoid arthritis
- stem cells
- induced apoptosis
- hyaluronic acid
- disease activity
- cell cycle arrest
- oxidative stress
- mesenchymal stem cells
- chronic pain
- ankylosing spondylitis
- cell therapy
- adipose tissue
- gene expression
- endoplasmic reticulum stress
- cell death
- dna methylation
- squamous cell carcinoma
- pain management
- systemic lupus erythematosus
- neuropathic pain
- cell proliferation
- high intensity
- radiation therapy
- systemic sclerosis
- lymph node
- extracellular matrix